儿童低级别胶质瘤:LMIC三级医院12年回顾性研究
该研究回顾了巴基斯坦Aga Khan大学医院2013至2025年间191例≤18岁儿童低级别胶质瘤的临床特征、治疗与结局。多数为幕上肿瘤且以毛细胞星形细胞瘤最常见,85.3%接受 upfront 手术,总生存率95.3%,中位无事件生存期84.2个月。
要点
- 儿童低级别胶质瘤以幕上、毛细胞星形细胞瘤为主,头痛呕吐常见。
- upfront 手术率85.3%,全切率52.1%,辅助放化疗比例低。
- 总生存率95.3%,中位EFS 84.2个月,但随访短需谨慎解读。
核心结论
- 尽管组织病理和部位异质,结局与文献相当,提示当前实践有效,但资源有限地区需改进随访和结局报告。
研究设计与样本
- 单中心回顾性队列研究,纳入2013至2025年Aga Khan大学医院≤18岁诊断为低级别胶质瘤的患者191例。
主要发现
- 男性占51.3%,中位年龄10岁(IQR 6-14),10-18岁组占50.3%。
- 症状中位持续时间4个月(IQR 1-18),头痛112例(58.6%),呕吐93例(48.7%)。
- 幕上肿瘤115例(60.2%),毛细胞星形细胞瘤119例。
- 无进展131例(68.6%),进展36例(18.8%),复发7例(3.7%),无随访扫描17例(8.9%)。
关键数值与推荐
- 活检推迟28例(14.7%),其中SEGA 17例(60.7%)、顶盖胶质瘤3例(10.7%)、视路胶质瘤5例(17.8%)。
临床怎么用
- 儿童低级别胶质瘤以手术为主要初始治疗,全切者预后良好。
- 对SEGA、顶盖胶质瘤和视路胶质瘤等可考虑推迟活检。
- 需加强术后随访扫描,避免失访。
局限性
- 中位随访时间相对较短且存在大量右删失,EFS估计需谨慎解读。
- 单中心回顾性设计,资源有限地区结果外推受限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVE: Central Nervous System (CNS) tumors are the leading solid malignancies in children, 50% of CNS tumors in children are glial tumors, with two-thirds of these gliomas being categorized as low-grade gliomas (LGG). We aimed to review the clinical profile, management, and outcomes of pediatric LGG cases. METHODOLOGY: A retrospective cohort study was conducted at Aga Khan University Hospital between 2013 and 2025 including patients aged ≤ 18 years diagnosed with LGG. RESULTS: A total of 191 patients were identified, with a slight preponderance of male patients (51.3%). Median age was 10 years (IQR 6-14) with the larger age group being 10-18 years (50.3%). Median duration of presenting symptoms was 4 months (IQR 1-18). Headaches (n = 112, 58.6%) and vomiting (n = 93, 48.7%) were the primary presenting complaints. Tumors were predominantly supratentorial (n = 115, 60.2%). The most common histopathology was Pilocytic Astrocytoma (n = 119). Upfront surgery was done in 163 (85.3%) patients; Gross Total Resection (GTR) was achieved in 85 patients (52.1%). Twenty-six (13.7%) patients received Chemotherapy while 9 (4.8%) had radiation therapy. Disease didn't progress in 131 (68.6%) patients while progression and relapse occurred in 36 (18.8%) and 7 (3.7%) patients, respectively. Seventeen (8.9%) patients did not have any follow-op scans. The Overall Survival (OS) was 95.3%, with only 9 deaths recorded. Biopsy was deferred to 28 patients (14.7%), a group primarily comprising Subependymal Giant Cell Astrocytomas (SEGA) (n = 17, 60.7%), Tectal Plate Glioma (n = 3, 10.7%), and Optic Path Glioma (n = 5, 17.8%). Kaplan-Meier analysis estimated a median EFS of 84.2 months (95% CI: 70.9-97.5 months). However, this estimate should be interpreted cautiously given the relatively short median follow-up and substantial right-censoring. CONCLUSION: Despite heterogeneity in histopathology and location, outcomes were comparable to those reported in the literature, underscoring the effectiveness of current practices while highlighting the need for improved follow-up and comprehensive outcome reporting in resource-limited settings.
引用
- Mushtaq N, Bashir F, Zahid S, et al. Pediatric low-grade gliomas; a 12-year retrospective review from a tertiary care hospital in LMIC. J Neurooncol. 2026. PMID: 42126672. doi:10.1007/s11060-026-05594-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。